# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA656067 | F | Concentration required to reduce proliferation of CD4+ human acuteT-lymphoblastic leukemia (CCRF-CEM) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
2. | ALA651471 | F | Concentration required to reduce proliferation of human acute B-lymphoblastic (CCRF-SB) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
3. | ALA653612 | F | Concentration required to reduce proliferation of human foreskin fibroblasts (CRL7065) cell line by 50% as determined by the MTT method; nd = not determined | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
4. | ALA668067 | F | Concentration required to reduce proliferation of human prostate carcinoma (DU-145) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
5. | ALA696818 | F | Concentration required to reduce proliferation of human hepatocellular carcinoma (HepG-2) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
6. | ALA710209 | F | Concentration required to reduce proliferation of human breast adenocarcinoma (MCF-7) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
7. | ALA713939 | F | Concentration required to reduce proliferation of CD4+ human acute T-lymphoblastic leukemia (MT-4) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
8. | ALA873247 | F | Concentration required to reduce proliferation of human breast adenocarcinoma (SKMEL-28) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
9. | ALA882602 | F | Concentration required to reduce proliferation of human lung squamous carcinoma (SKMES-1) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
10. | ALA822285 | F | Concentration required to reduce proliferation of human splenic B-lymphoblastoid (Wil2-NS) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature |